Rydapt Capsule, Liquid Filled
Product Images NDC 0078-0698

3 FDA label images from Novartis Pharmaceuticals Corporation · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Rydapt (NDC 0078-0698). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Novartis Pharmaceuticals Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Structural Formula (Rydapt 01)

Structural Formula (Rydapt 01)
Chemical structure diagram of the active ingredient in RYDAPT 25 mg liquid-filled oral capsules. The diagram shows the molecular arrangement with labeled stereochemistry and bonds of the compound associated with this pharmaceutical product by Novartis Pharmaceuticals Corporation.*
FDA Label Image

Figure 1: Kaplan-meier Curve For Overall Survival In Study 1 (Rydapt 02)

Figure 1: Kaplan-meier Curve For Overall Survival In Study 1 (Rydapt 02)
A Kaplan-Meier survival curve chart showing overall survival probability (%) over time in months comparing RYDAPT (n=360) and placebo (n=357). The chart includes a hazard ratio (HR) of 0.77 (95% CI, 0.629-0.953) and a significance p-value of 0.016. The number of patients at risk for each time point is displayed below the x-axis for both Midostaurin (RYDAPT) and placebo groups.*
FDA Label Image

Principal Display Panel Rydapt® Ndc 0078-0698-99 (midostaurin) Capsules 25 mg Rx Only 56 Soft Capsules Contents: 2 Packs Containing 28 Capsules Each Novartis (Rydapt 03)

Principal Display Panel Rydapt® Ndc 0078-0698-99 (midostaurin) Capsules 25 mg Rx Only 56 Soft Capsules Contents: 2 Packs Containing 28 Capsules Each Novartis (Rydapt 03)
RYDAPT 25 mg capsules liquid filled capsule carton for oral use. Contains 56 soft capsules in 2 packs of 28 each. Manufactured by Catalent Germany and distributed by Novartis Pharmaceuticals Corporation. The label indicates the active ingredient midostaurin and includes storage instructions and contact information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.